Clinical Trial

A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study will assess the pharmacokinetics and relative Bioavailability of risankizumab following subcutaneous administration with an on-body injector relative to a prefilled syringe
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-05-28; most recent amendment 2026-01-26.
Status change: Active, Not Recruiting → Completed 2026-01-26
Status change: Recruiting → Active, Not Recruiting 2025-08-25
Status change: Not Yet Recruiting → Recruiting 2025-06-16
Trial Details
NCT Number NCT07007091
Lead Sponsor AbbVie
Conditions Healthy Volunteers
Enrollment 260 participants
Start Date 2025-06-12
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-27